Literature DB >> 20408531

Novel ferrocenic steroidal drug derivatives and their bioactivities.

Jiradej Manosroi1, Kanjana Rueanto, Korawinwich Boonpisuttinant, Worapaka Manosroi, Christophe Biot, Hiroyuki Akazawa, Toshihiro Akihisa, Witchapong Issarangporn, Aranya Manosroi.   

Abstract

Seven novel ferrocenic derivatives, compounds 1-7, were synthesized from steroidal drugs by Aldol condensation reaction. The derivatives were purified by chromatography, and their structures were determined on the basis of HR-ESI-MS and two-dimensional NMR spectroscopy. The purity of all derivatives was more than 95%. Compounds 1-5 demonstrated anti-proliferative activity on HeLa cell line by SRB assay more than their parent compounds. All seven derivatives showed anti-oxidative activities evaluated by DPPH scavenging and metal ion chelating, while their parent compounds gave no activity. Compound 1 indicated the most potent anti-proliferative activity similar to doxorubicin, with the GI(50) at 0.223 +/- 0.014 microg/mL. Compounds 6 and 7 demonstrated similar potent in vivo anti-inflammatory to their parent compounds (prednisolone and hydrocortisone) at 80.99 +/- 13.5 and 68.24 +/- 10.4% edema inhibition, respectively. This study has suggested that the novel compound 1 was the most potential derivative that can be further developed for cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20408531     DOI: 10.1021/jm901866m

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Steroidal ferrocenes as potential enzyme inhibitors of the estrogen biosynthesis.

Authors:  Bianka Edina Herman; János Gardi; János Julesz; Csaba Tömböly; Eszter Szánti-Pintér; Klaudia Fehér; Rita Skoda-Földes; Mihály Szécsi
Journal:  Biol Futur       Date:  2020-06-25

2.  Metallocenes as Target Specific Drugs for Cancer Treatment.

Authors:  Enrique Meléndez
Journal:  Inorganica Chim Acta       Date:  2012-06-21       Impact factor: 2.545

Review 3.  Ferrocene-Based Compounds with Antimalaria/Anticancer Activity.

Authors:  Sijongesonke Peter; Blessing Atim Aderibigbe
Journal:  Molecules       Date:  2019-10-07       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.